首页> 外文期刊>Protein Expression and Purification >A new metal affinity NCTR25 tag as a better alternative to the His-tag for the expression of recombinant fused proteins
【24h】

A new metal affinity NCTR25 tag as a better alternative to the His-tag for the expression of recombinant fused proteins

机译:一种新的金属亲和力NCTR25标签作为其标签的更好的替代品,用于表达重组融合蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

His-tagging is commonly used in fusion protein production, but the His-tag is usually prohibited in medicinal proteins and must be removed. A fragment (NCTR25-tag) truncated from the N-terminus of human copper transporter 1 was tested for feasibility as a replacement for the His-tag in fusion proteins. The NCTR25-tag and His-tag were separately fused to the transthyretin (TTR) protein, and the expression, affinity purification, refolding and stability of the two kinds of fusions were compared. NCTR25 fusion produced a 63% higher yield of the recombinant protein, which was purified by metal affinity chromatography with an efficiency similar to that of His-tagged protein. NCTR25 -tag fusion had much less impact on the foldability, kinetic and thermodynamic stability of tetrameric TTR than His-tag fusion. When the tags were individually fused to enhanced green fluorescent protein (EGFP), NCTR25 fusion yielded 29-128% more product than His-EGFP. NCTR25-EGFP could be purified by metal affinity chromatography and showed better foldability than His-EGFP. Furthermore, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) fusion with the third disulfide loop of TGF-alpha (TGF3L-TRAIL) fused with the NCTR25-tag retained the stability and superactivity of His-TGF3L-TRAIL. Therefore, the native tag NCTR25-tag is a feasible alternative to the His-tag in medicinal recombinant proteins.
机译:他的标记通常用于融合蛋白质生产,但他标签通常禁止在药物蛋白中,并且必须除去。从人铜转运蛋白1的N-末端截短的片段(NCTR25标签)进行可行性作为融合蛋白中的HIS标签的可行性。将NCTR25标签和HIS-TAG分别融合到Transthyretin(TTR)蛋白,并比较了两种融合的表达,亲和纯化,重折叠和稳定性。 NCTR25融合产生重组蛋白质的63%,通过金属亲和色谱法纯化,其效率类似于其标记蛋白质的效率。 NCTR25 -TAG融合对四聚体TTR的可折叠性,动力学和热力学稳定性的影响大得多而不是His标签融合。当标签被单独融合到增强的绿色荧光蛋白(EGFP)时,NCTR25融合产生的产品比他的EGFP更多。 NCTR25-EGFP可以通过金属亲和层析纯化,并且显示比他的EGFP更好的可折叠性。此外,肿瘤坏死因子(TNF)相关的凋亡诱导配体(TRAP)与与NCTR25标签融合的TGF-α(TGF3L-TRAP)的第三二硫化物环保留了HIS-TGF3L-TRAIL的稳定性和超常性。因此,NCTR25标签NCTR25标签是药用重组蛋白中的HIS标签的可行替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号